Trust standard

Editorial & Evidence Policy

How EonVita separates established knowledge, promising research and commercial activity.

Our hierarchy

EonVita gives priority to established health fundamentals and high-quality human evidence. Mechanistic, animal and preliminary findings may be discussed, but they are not presented as equivalent to clinical outcomes.

Evidence labels

Our working categories are Strong Evidence, Good Evidence, Emerging Evidence and Experimental / Research Frontier. A rating applies to a specific claim or use, not automatically to an ingredient or intervention in every context.

Sources

Detailed articles should favour systematic reviews, meta-analyses, major clinical trials, established professional guidance and authoritative public-health sources where appropriate.

Updates and corrections

Important guides should display a review or update date. Material errors should be corrected rather than silently preserved for consistency.

Commercial separation

A future EonVita product, affiliate relationship or commercial partnership does not earn a higher evidence rating. Where a commercial relationship is relevant to an article, it should be disclosed.

What EonVita does not promise

We do not promise immortality, guaranteed disease prevention, reversal of biological age or universal supplement stacks.